MA, P., M, C., JL, C., NB, G., JA, M., JJ, O., . . . MP, W. (2023). When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective. American journal of medical genetics. Part C, Seminars in medical genetics, 193(1), 44. https://doi.org/10.1002/ajmg.c.32036
Chicago Style (17th ed.) CitationMA, Parisi, Caggana M, Cohen JL, Gold NB, Morris JA, Orsini JJ, Urv TK, and Wasserstein MP. "When Is the Best Time to Screen and Evaluate for Treatable Genetic Disorders?: A Lifespan Perspective." American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 193, no. 1 (2023): 44. https://doi.org/10.1002/ajmg.c.32036.
MLA (9th ed.) CitationMA, Parisi, et al. "When Is the Best Time to Screen and Evaluate for Treatable Genetic Disorders?: A Lifespan Perspective." American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, vol. 193, no. 1, 2023, p. 44, https://doi.org/10.1002/ajmg.c.32036.